We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 57

Latest developments in standards, patents and FRAND licensing

  • CMS Cameron McKenna
  • -
  • European Union, United Kingdom
  • -
  • June 13 2013

Since the publication of the European Commission's revised Guidelines on the applicability of Article 101 of the Treaty on the Functioning of the

Commission (again) concerned with SEP injunctions

  • McGuireWoods LLP
  • -
  • European Union
  • -
  • June 3 2013

On 6 May 2013, the European Commission (EC) indicated that its preliminary view is that Motorola Mobility has abused a dominant position by seeking

General counsel update

  • Herbert Smith Freehills LLP
  • -
  • China, European Union, Germany, Hong Kong, Indonesia, Mongolia, Singapore, United Kingdom, USA
  • -
  • July 11 2012

This is the thirtieth in our series of general counsel updates which aim to summarise major developments in key areas

AstraZeneca judgment: don’t game the system

  • CMS Cameron McKenna
  • -
  • European Union
  • -
  • December 12 2012

In a long-awaited judgment dated 6 December 2012, the European Court of Justice (ECJ) has confirmed that certain brand protection strategies may infringe the EU competition rules

European Commission consults on revised competition regime for technology transfer agreements

  • Covington & Burling LLP
  • -
  • European Union
  • -
  • February 26 2013

On 20 February 2013, the European Commission published for consultation its proposal for revisions to the EU technology transfer competition regime

"Pay for delay" agreements

  • Taylor Wessing LLP
  • -
  • European Union
  • -
  • April 30 2013

"Pay for delay" agreements are a form of patent dispute settlement agreement in which a generic manufacturer acknowledges the patent of the

A new front in the patent wars: CJEU asked for guidance on limits to injunctive relief

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • April 11 2013

The patent wars between large technology companies continue unabated. The Court of Justice of the European Union (CJEU) is set to provide guidance on

EU political update 25 February - 1 March 2013

  • Clifford Chance LLP
  • -
  • European Union
  • -
  • February 25 2013

As we reported in last week's EU Political Update, on 13 February 2013, the Commission issued a Product Safety and Market Surveillance package which

Advocate General's opinion in AstraZeneca appeal published

  • Herbert Smith Freehills LLP
  • -
  • European Union
  • -
  • May 17 2012

In July 2010 the General Court handed down its judgment in which it upheld the Commission's decision finding that AstraZeneca had abused its dominant position under Article 102 TFEU by misusing the patent system and pharmaceutical marketing procedures in order to exclude generic competitors to its ulcer drug Losec from the market and to restrict parallel imports of the drug

European Commission brings “reverse payment” cases against pharmaceutical companies

  • Orrick Herrington & Sutcliffe LLP
  • -
  • European Union
  • -
  • September 17 2012

On July 30, 2012, the Commission announced that it had issued formal charges (a “Statement of Objections”) against Servier, a pharmaceutical company, and several of its generic competitors

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy